{"entity":{"type":"insider","cik":"0001791412","url":"/insider/0001791412","json_url":"/insider/0001791412.json","name":"Nabulsi Azmi","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":12,"first":"2020-11-03","last":"2025-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Nabulsi Azmi","source":"filing","n_filings":12,"first_seen":"2020-11-03","last_seen":"2025-01-23"}],"transactions":[{"id":4027174,"accession":"0000950170-25-008353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-008353","line_url":"/filing/0000950170-25-008353#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7886.0,"shares_display":"7,886","price_per_share":6.5885,"price_display":"6.59","price_state":"stated","total_value":51956.911,"total_display":"51,956.91","total_whole":"51,957","shares_owned_after":233390.0,"shares_owned_after_display":"233,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":2181984,"accession":"0000950170-24-139063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-139063","line_url":"/filing/0000950170-24-139063#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1118.0,"shares_display":"1,118","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":8944.0,"total_display":"8,944.00","total_whole":"8,944","shares_owned_after":239303.0,"shares_owned_after_display":"239,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2637738,"accession":"0000950170-24-084186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084186","line_url":"/filing/0000950170-24-084186#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10901.0,"shares_display":"10,901","price_per_share":11.72,"price_display":"11.72","price_state":"stated","total_value":127759.72,"total_display":"127,759.72","total_whole":"127,760","shares_owned_after":240421.0,"shares_owned_after_display":"240,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-17","scope":"insider"},{"id":8153165,"accession":"0001209191-23-023989","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023989","line_url":"/filing/0001209191-23-023989#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.26,"price_display":"8.26","price_state":"stated","total_value":82600.0,"total_display":"82,600.00","total_whole":"82,600","shares_owned_after":99567.0,"shares_owned_after_display":"99,567","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-11","filed_date":"2023-04-11","scope":"insider"},{"id":6630453,"accession":"0001209191-22-029453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-029453","line_url":"/filing/0001209191-22-029453#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":8.1644,"price_display":"8.16","price_state":"stated","total_value":163288.0,"total_display":"163,288.00","total_whole":"163,288","shares_owned_after":785700.0,"shares_owned_after_display":"785,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":4139175,"accession":"0001209191-21-030141","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-030141","line_url":"/filing/0001209191-21-030141","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4457.0,"shares_display":"4,457","price_per_share":36.86377565627103,"price_display":"36.86","price_state":"stated","total_value":164301.8481,"total_display":"164,301.85","total_whole":"164,302","shares_owned_after":768189.0,"shares_owned_after_display":"768,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-04","scope":"insider","n_lines":3},{"id":4139169,"accession":"0001209191-21-030141","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-030141","line_url":"/filing/0001209191-21-030141","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10043.0,"shares_display":"10,043","price_per_share":38.27085848849945,"price_display":"38.27","price_state":"stated","total_value":384354.2318,"total_display":"384,354.23","total_whole":"384,354","shares_owned_after":770157.0,"shares_owned_after_display":"770,157","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-04","scope":"insider","n_lines":2},{"id":5424278,"accession":"0001209191-21-025456","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-025456","line_url":"/filing/0001209191-21-025456","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9353.0,"shares_display":"9,353","price_per_share":36.109608371645464,"price_display":"36.11","price_state":"stated","total_value":337733.1671,"total_display":"337,733.17","total_whole":"337,733","shares_owned_after":780985.0,"shares_owned_after_display":"780,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-05","scope":"insider","n_lines":3},{"id":5424269,"accession":"0001209191-21-025456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-025456","line_url":"/filing/0001209191-21-025456","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5147.0,"shares_display":"5,147","price_per_share":37.56918966388187,"price_display":"37.57","price_state":"stated","total_value":193368.6192,"total_display":"193,368.62","total_whole":"193,369","shares_owned_after":791295.0,"shares_owned_after_display":"791,295","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-05","scope":"insider","n_lines":2},{"id":5374694,"accession":"0001209191-21-017484","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-017484","line_url":"/filing/0001209191-21-017484","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9127.0,"shares_display":"9,127","price_per_share":45.899898301742084,"price_display":"45.90","price_state":"stated","total_value":418928.3718,"total_display":"418,928.37","total_whole":"418,928","shares_owned_after":798394.0,"shares_owned_after_display":"798,394","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-03","scope":"insider","n_lines":5},{"id":5374680,"accession":"0001209191-21-017484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017484","line_url":"/filing/0001209191-21-017484","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5373.0,"shares_display":"5,373","price_per_share":45.851796984924626,"price_display":"45.85","price_state":"stated","total_value":246361.7052,"total_display":"246,361.71","total_whole":"246,362","shares_owned_after":805375.0,"shares_owned_after_display":"805,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider","n_lines":2},{"id":5393546,"accession":"0001209191-21-007185","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-007185","line_url":"/filing/0001209191-21-007185","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9084.0,"shares_display":"9,084","price_per_share":40.96824398943197,"price_display":"40.97","price_state":"stated","total_value":372155.5284,"total_display":"372,155.53","total_whole":"372,156","shares_owned_after":809200.0,"shares_owned_after_display":"809,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":5393538,"accession":"0001209191-21-007185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-007185","line_url":"/filing/0001209191-21-007185#line-1","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5416.0,"shares_display":"5,416","price_per_share":38.0881,"price_display":"38.09","price_state":"stated","total_value":206285.1496,"total_display":"206,285.15","total_whole":"206,285","shares_owned_after":818284.0,"shares_owned_after_display":"818,284","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":3285489,"accession":"0001209191-20-061593","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-061593","line_url":"/filing/0001209191-20-061593","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7302.0,"shares_display":"7,302","price_per_share":45.263284031772116,"price_display":"45.26","price_state":"stated","total_value":330512.5,"total_display":"330,512.50","total_whole":"330,513","shares_owned_after":841195.0,"shares_owned_after_display":"841,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-02","filed_date":"2020-12-03","scope":"insider","n_lines":2},{"id":3285482,"accession":"0001209191-20-061593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-061593","line_url":"/filing/0001209191-20-061593","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7198.0,"shares_display":"7,198","price_per_share":44.203325923867745,"price_display":"44.20","price_state":"stated","total_value":318175.54,"total_display":"318,175.54","total_whole":"318,176","shares_owned_after":847330.0,"shares_owned_after_display":"847,330","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider","n_lines":2},{"id":2444836,"accession":"0001209191-20-056768","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-056768","line_url":"/filing/0001209191-20-056768#line-3","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":36.8294,"price_display":"36.83","price_state":"stated","total_value":534026.3,"total_display":"534,026.30","total_whole":"534,026","shares_owned_after":852700.0,"shares_owned_after_display":"852,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":5512779,"accession":"0001209191-21-001622","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-001622","line_url":"/filing/0001209191-21-001622#line-4","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1854.0,"shares_display":"1,854","price_per_share":33.7694,"price_display":"33.77","price_state":"stated","total_value":62608.4676,"total_display":"62,608.47","total_whole":"62,608","shares_owned_after":823700.0,"shares_owned_after_display":"823,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-05","filed_date":"2021-01-05","scope":"insider"},{"id":5512778,"accession":"0001209191-21-001622","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-001622","line_url":"/filing/0001209191-21-001622","is_derivative":false,"issuer_cik":"0001783183","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001783183","owner_cik":"0001791412","owner_name":"Nabulsi Azmi","owner_display_name":"Nabulsi Azmi","owner_url":"/insider/0001791412","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12646.0,"shares_display":"12,646","price_per_share":33.58106923928515,"price_display":"33.58","price_state":"stated","total_value":424666.2016,"total_display":"424,666.20","total_whole":"424,666","shares_owned_after":825654.0,"shares_owned_after_display":"825,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-04","filed_date":"2021-01-05","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001783183","name":"Phathom Pharmaceuticals, Inc.","url":"/issuer/0001783183","role":"Officer (Chief Operating Officer)","n_filings":12,"first_seen":"2020-11-03","last_seen":"2025-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001791412","retrieved_at":"2026-08-25T14:31:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}